If you need more lookups,
subscriptions start at $34 USD/month.
Craig Biggs Location
Vancouver, WA, US
Craig Biggs Work
2022 -now Senior Director, Medical Affairs @
2020 -2022 Medical Affairs Executive Director @
2016 -2022 Senior Managed Care Liaison @
2015 -2016 Senior Director Medical Affairs @
2014 -2015 Director of Medical Science Liaisons and Health Economics Outcomes Research @
2013 -2015 Director, Medical Science Liaisons @
2012 -2013 Director, Medical Science Liaisons and Medical Information Service @
2011 -2012 Health Outcomes, Pharmacoeconomic Research @
2010 -2011 Associate Director-Medical Information @
2008 -2009 National Manager, Clinical Science Managers @
2003 -2008 Regional Manager @
1998 -2002 MSL @
1991 -1993 Regional Pharm Ops Manager @ HNS
1985 -1987 Pharmacy Resident @
Craig Biggs Education
University of Washington
(Economics)
2014-2015
University of Washington
Doctor Of Pharmacy (Pharmacy)
2002-2006
University of Washington
Master Of Public Health
1985-1988
University of Washington
Bachelors (Pharmacy)
1979-1985
Craig Biggs Skills
Urology
Clinical Trials
Nephrology
Cardiology
Dermatology
Gastroenterology
Neurology
Infectious Diseases
Pulmonology
Clinical Research
Biotechnology
Immunology
Hematology
Strategic Planning
Hospital Sales
Medicine
Oncology
Clinical Development
Managed Care
Biologics
Endocrinology
Diabetes
Management
Informatics
Research
Pharmaceutical Industry
Rheumatology
Pharmaceutical Sales
Market Access
Therapeutic Areas
Medical Affairs
Biopharmaceuticals
Craig Biggs Summary
Craig Biggs, based in Vancouver, WA, US, is currently a Senior Director, Medical Affairs at Regeneron Pharmaceuticals, Inc.. Craig Biggs brings experience from previous roles at Genentech, Newlink Genetics and Dendreon. Craig Biggs holds a 2014 - 2015 University of Washington. With a robust skill set that includes Urology, Clinical Trials, Nephrology, Cardiology, Dermatology and more. Craig Biggs has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Craig Biggs?
Find contact details for 700 million professionals.